Laser prostate vaporization (GreenLight) · Ohio
Laser prostate vaporization (GreenLight) in Ohio: the highest-volume physicians
25 physicians in Ohio billed Medicare for 599 laser prostate vaporization (GreenLight) procedures in 2024. The top 25, with the year before beside it.
Top 25
| Rank | Physician | 2024 | 2023 | Change |
|---|---|---|---|---|
| 1 | Benjamin R. Gibson, MDUrology · Cambridge | 65 | 48 | +35% |
| 2 | Omar A. Khan, MDUrology · Toledo | 61 | 60 | +2% |
| 3 | Saleem S. Zafar, MDUrology · Toledo | 52 | 34 | +53% |
| 4 | Bradley C. Gill, MDUrology · Mayfield Heights | 36 | 50 | −28% |
| 5 | Juan A. Jimenez, MD, PHDUrology · Cleveland | 29 | — | |
| 6 | Thomas G. Zaciewski, MDUrology · Tiffin | 27 | 31 | −13% |
| 6 | Carson Wong, MDUrology · Marietta | 27 | 17 | |
| 8 | Michael D. Jordan, DOUrology · Marysville | 26 | 45 | −42% |
| 9 | Bradley J. Buck, MDUrology · Toledo | 23 | 44 | −48% |
| 10 | Daniel S. Murtagh, MDUrology · Toledo | 22 | 26 | −15% |
| 11 | William E. Bloch, MDUrology · Worthington | 21 | 21 | +0% |
| 11 | Hesham I. Mostafa, MDUrology · Toledo | 21 | 19 | |
| 13 | James C. Ulchaker, MDUrology · Cleveland | 20 | 42 | −52% |
| 14 | Frederic J. Levine, MDUrology · Willoughby | 16 | 22 | −27% |
| 14 | Scott D. Cohen, MDUrology · Celina | 16 | 22 | −27% |
| 16 | Mirza M. Baig, MDUrology · Toledo | 15 | 16 | |
| 16 | Brian J. Minnillo, MDUrology · Cincinnati | 15 | 15 | |
| 16 | Matthew R. Riebel, MDUrology · Worthington | 15 | — | |
| 16 | Andrew L. Altman, MDUrology · Cleveland Heights | 15 | — | |
| 16 | Charles S. Woolums, MDUrology · Portsmouth | 15 | 25 | −40% |
| 21 | Philip C. Aschi, DOUrology · Wilmington | 14 | — | |
| 21 | Salvador E. Peron, MDUrology · Toledo | 14 | — | |
| 23 | Jeffrey C. Lapeyrolerie, MDUrology · Garfield Hts | 12 | 15 | |
| 24 | Stephen C. Johnson, MDUrology · Chillicothe | 11 | — | |
| 24 | Joshua J. EbelUrology · Findlay | 11 | — |
A rank counts procedures billed under the physician's own NPI (CPT 52648), in 2024, Medicare fee-for-service only. A surgeon who mostly treats younger or Medicare Advantage patients will rank lower than their total volume. Method and limits.